Clinical TrialsVerastem Reports Encouraging Phase 1/2 Results for KRAS G12D Inhibitor VS-7... Verastem Reports Encouraging Phase 1/2 Results for KRAS G12D Inhibitor VS-7... Read Post »
Clinical TrialsRevMed Advances Zoldonrasib into Phase 3 Pancreatic Cancer Trial RevMed Advances Zoldonrasib into Phase 3 Pancreatic Cancer Trial Read Post »
Clinical TrialsCorxel Reports Positive Results for Oral GLP-1 CX11 in Obesity Corxel Reports Positive Results for Oral GLP-1 CX11 in Obesity Read Post »
Clinical TrialsTScan Reports Strong Phase 1 Results for TSC-101 Ahead of Phase 3 Trial TScan Reports Strong Phase 1 Results for TSC-101 Ahead of Phase 3 Trial Read Post »
Clinical TrialsPP-01 Advances Toward Becoming First Approved Treatment for Cannabis Withdr... PP-01 Advances Toward Becoming First Approved Treatment for Cannabis Withdr... Read Post »
Clinical TrialsExelixis Reports Positive Final STELLAR-303 Survival Data in Metastatic Col... Exelixis Reports Positive Final STELLAR-303 Survival Data in Metastatic Col... Read Post »
Clinical TrialsFDA Grants Priority Review for Tivicay PD to Treat HIV in Newborns from Bir... FDA Grants Priority Review for Tivicay PD to Treat HIV in Newborns from Bir... Read Post »
Clinical TrialsPfizer’s Sigvotatug Vedotin Misses Overall Survival Endpoint in Phase 3 N... Pfizer’s Sigvotatug Vedotin Misses Overall Survival Endpoint in Phase 3 N... Read Post »
Clinical TrialsDefinium’s DT120 Succeeds in Phase 3 Trial for Major Depression Definium’s DT120 Succeeds in Phase 3 Trial for Major Depression Read Post »
Clinical TrialsBoehringer Advances Late-Stage Oncology Pipeline with Three Global Phase II... Boehringer Advances Late-Stage Oncology Pipeline with Three Global Phase II... Read Post »
Clinical TrialsMerck’s Tulisokibart Shows Strong Phase 3 Efficacy in Ulcerative Colitis Merck’s Tulisokibart Shows Strong Phase 3 Efficacy in Ulcerative Colitis Read Post »
Clinical TrialsCynata’s Pivotal aGvHD and Osteoarthritis Trials Miss Primary Endpoints Cynata’s Pivotal aGvHD and Osteoarthritis Trials Miss Primary Endpoints Read Post »
Clinical TrialsInnovent Advances IBI3003 into Phase 3 Testing for Multiple Myeloma Innovent Advances IBI3003 into Phase 3 Testing for Multiple Myeloma Read Post »
Clinical TrialsMoonLake Reports Strong One-Year Phase 3 Results for Sonelokimab in Hidrade... MoonLake Reports Strong One-Year Phase 3 Results for Sonelokimab in Hidrade... Read Post »
Clinical TrialsRezolute Presents New Ersodetug Analyses Following Mixed Phase 3 Results Rezolute Presents New Ersodetug Analyses Following Mixed Phase 3 Results Read Post »
Clinical TrialsSuven’s Ropanicant Improves Depression Scores in Phase 2b Trial Suven’s Ropanicant Improves Depression Scores in Phase 2b Trial Read Post »
Clinical TrialsSuven’s SUVN-I6107 Shows Early Cognitive Benefits and CNS Activity in Pha... Suven’s SUVN-I6107 Shows Early Cognitive Benefits and CNS Activity in Pha... Read Post »
Clinical TrialsJohnson & Johnson Reports Positive MEMBRANE Trial Results Demonstrating... Johnson & Johnson Reports Positive MEMBRANE Trial Results Demonstrating... Read Post »
Clinical TrialsuniQure Reports Positive Data for AMT-260 in Drug-Resistant Epilepsy uniQure Reports Positive Data for AMT-260 in Drug-Resistant Epilepsy Read Post »
Clinical TrialsFDA Clears IND for CSPC’s Monthly Octreotide in U.S. Acromegaly Trial FDA Clears IND for CSPC’s Monthly Octreotide in U.S. Acromegaly Trial Read Post »
Clinical TrialsEnanta Advances Zelicapavir into Registrational RSV Trial Enanta Advances Zelicapavir into Registrational RSV Trial Read Post »
Clinical TrialsEdgewise Reports Positive Phase 2 CIRRUS-HCM Results for EDG-7500 Edgewise Reports Positive Phase 2 CIRRUS-HCM Results for EDG-7500 Read Post »
Clinical TrialsProJenX Reports Positive Data for First-in-Class CNS-Penetrant Prosetin in ... ProJenX Reports Positive Data for First-in-Class CNS-Penetrant Prosetin in ... Read Post »
Clinical TrialsAlkermes Reports Positive Results for Alixorexton in Narcolepsy Type 2 Alkermes Reports Positive Results for Alixorexton in Narcolepsy Type 2 Read Post »
Clinical TrialsNerandomilast Extends Projected Survival by Up to 5.4 Years in IPF Nerandomilast Extends Projected Survival by Up to 5.4 Years in IPF Read Post »
Clinical TrialsShionogi and F2G Report Positive Phase 3 Results for Olorofim in Invasive A... Shionogi and F2G Report Positive Phase 3 Results for Olorofim in Invasive A... Read Post »
Clinical TrialsHumacyte’s ATEV Improves Dialysis Access and Reduces Infections in Women Humacyte’s ATEV Improves Dialysis Access and Reduces Infections in Women Read Post »
Clinical TrialsBrain Communications Data Show KYGEVVI Reduces Death Risk by Up to 94% in E... Brain Communications Data Show KYGEVVI Reduces Death Risk by Up to 94% in E... Read Post »
Clinical TrialsMIRA Submits Phase 2a Trial Protocol for Ketamir-2 in CIPN MIRA Submits Phase 2a Trial Protocol for Ketamir-2 in CIPN Read Post »
Clinical TrialsBioMarin Reports Long-Term VOXZOGO Growth Benefits in Hypochondroplasia, Ad... BioMarin Reports Long-Term VOXZOGO Growth Benefits in Hypochondroplasia, Ad... Read Post »
Clinical TrialsSedana Medical Files NDA for Isoflurane ICU Sedation System Sedana Medical Files NDA for Isoflurane ICU Sedation System Read Post »
Clinical TrialsFDA Agrees AMT-130 Data Can Support Huntington’s Disease BLA FDA Agrees AMT-130 Data Can Support Huntington’s Disease BLA Read Post »
Clinical TrialsJazz Highlights New Xywav Data Showing Cardiometabolic Benefits and Persona... Jazz Highlights New Xywav Data Showing Cardiometabolic Benefits and Persona... Read Post »
Clinical TrialsRhythm Highlights Long-Term Setmelanotide and Bivamelagon Data Across Rare ... Rhythm Highlights Long-Term Setmelanotide and Bivamelagon Data Across Rare ... Read Post »
Clinical TrialsVYKAT XR Shows Durable Hyperphagia and Behavioral Benefits in PWS VYKAT XR Shows Durable Hyperphagia and Behavioral Benefits in PWS Read Post »
Clinical TrialsOveporexton Improves Daily Functioning and Sleep in Narcolepsy Type 1 Oveporexton Improves Daily Functioning and Sleep in Narcolepsy Type 1 Read Post »
Clinical TrialsNeurocrine Highlights Broad Long-Term Benefits of CRENESSITY Across Adult, ... Neurocrine Highlights Broad Long-Term Benefits of CRENESSITY Across Adult, ... Read Post »
Clinical TrialsAnti-ACTH Antibody Asedebart Shows Strong Cortisol Control in Cushing’s D... Anti-ACTH Antibody Asedebart Shows Strong Cortisol Control in Cushing’s D... Read Post »
Clinical TrialsLegend Biotech Reports First-in-Human Proof-of-Concept for In Vivo CAR-T Cl... Legend Biotech Reports First-in-Human Proof-of-Concept for In Vivo CAR-T Cl... Read Post »
Clinical TrialsIncyte’s INCA033989 Delivers Durable Responses in CALR-Mutated MPNs at EH... Incyte’s INCA033989 Delivers Durable Responses in CALR-Mutated MPNs at EH... Read Post »
Clinical TrialsZilurgisertib Cuts New Bone Formation in FOP, FDA Grants Priority Review Zilurgisertib Cuts New Bone Formation in FOP, FDA Grants Priority Review Read Post »
Clinical TrialsJaypirca Regimen Cuts Progression Risk by 45% in Relapsed CLL Jaypirca Regimen Cuts Progression Risk by 45% in Relapsed CLL Read Post »
Clinical TrialsSun Pharma’s UNLOXCYT™ Delivers Durable Responses in Advanced CSCC Sun Pharma’s UNLOXCYT™ Delivers Durable Responses in Advanced CSCC Read Post »
Clinical TrialsSetmelanotide Lowers BMI and Improves Hyperphagia in Prader-Willi Syndrome Setmelanotide Lowers BMI and Improves Hyperphagia in Prader-Willi Syndrome Read Post »
Clinical TrialsAgios Presents Phase 3 RISE UP Results for Mitapivat in Sickle Cell Disease... Agios Presents Phase 3 RISE UP Results for Mitapivat in Sickle Cell Disease... Read Post »
Clinical TrialsfrontMIND Trial Meets Primary Endpoint in High-Risk DLBCL and HGBL frontMIND Trial Meets Primary Endpoint in High-Risk DLBCL and HGBL Read Post »
Clinical TrialsNovartis’ Rhapsido Delivers Positive Phase 3 Results in CIU Novartis’ Rhapsido Delivers Positive Phase 3 Results in CIU Read Post »
Clinical TrialsCogent Advances Bezuclastinib Toward NDA Submission With Positive APEX Resu... Cogent Advances Bezuclastinib Toward NDA Submission With Positive APEX Resu... Read Post »
Clinical TrialsJazz’s Phase 3 LAGOON Trial Fails to Improve Survival in Relapsed SCL... Jazz’s Phase 3 LAGOON Trial Fails to Improve Survival in Relapsed SCL... Read Post »
Clinical TrialsVenetoclax Plus Obinutuzumab Cuts Risk of Progression or Death by 50% in CL... Venetoclax Plus Obinutuzumab Cuts Risk of Progression or Death by 50% in CL... Read Post »
